Differently to U2OS cells, where cycle progression is regulated in a TP53-dependent manner [33], our results suggest that CHD4 can suppress cell cycle progression through CDKN1A up-regulation in breast cancer cells. This evidence concerns the gene TP53 and breast cancer.